Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 341

    Roche, Shire court fight escalates over haemophilia drug

    Roche, Shire court fight escalates over haemophilia drug

    Ruby Khatun Khatun19 Dec 2017 10:15 AM IST
    ZURICH: Roche’s patent dispute with London-listed Shire over the Swiss drugmaker’s new haemophilia drug Hemlibra has escalated, with Shire filing a...
    Allergan, Richters bipolar depression drug succeeds in key trial

    Allergan, Richter's bipolar depression drug succeeds in key trial

    Ruby Khatun Khatun19 Dec 2017 10:00 AM IST
    Allergan Plc and Hungary’s Gedeon Richter Plc said on Monday their drug to treat severe bipolar depression in adults met the main goal of a late-stage...
    FDA allows Alnylam to restart hemophilia treatment trials

    FDA allows Alnylam to restart hemophilia treatment trials

    Ruby Khatun Khatun19 Dec 2017 9:45 AM IST
    The U.S. Food and Drug Administration has allowed Alnylam Pharmaceuticals Inc to restart clinical trials on a drug to treat patients with a rare...
    FDA launches new tool for sharing information that allows doctors to better manage antibiotic use

    FDA launches new tool for sharing information that allows doctors to better manage antibiotic use

    Ruby Khatun Khatun19 Dec 2017 9:30 AM IST
    The U.S. Food and Drug Administration (FDA) is announcing a new approach to get critical updates regarding antibiotics and antifungal drugs to...
    Fortis Healthcare rejects over pricing of drugs charge

    Fortis Healthcare rejects over pricing of drugs charge

    Ruby Khatun Khatun18 Dec 2017 11:00 AM IST
    New Delhi: Fortis Healthcare has rejected charges of overpricing the medicines that it is giving to its patients.In a statement, it said, "Fortis...
    Novo Nordisk wins EU panel

    Novo Nordisk wins EU panel's backing for key diabetes drug

    Ruby Khatun Khatun18 Dec 2017 10:30 AM IST
    COPENHAGEN: Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, it's biggest growth prospect when a...
    Pfizer gets USFDA approval for second biosimilar of Remicade

    Pfizer gets USFDA approval for second biosimilar of Remicade

    Ruby Khatun Khatun18 Dec 2017 10:15 AM IST
    The U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson and Johnson's blockbuster rheumatoid arthritis drug,...
    Aclaris

    Aclaris's drug to treat common skin growth gets FDA nod

    Ruby Khatun Khatun18 Dec 2017 10:00 AM IST
    Aclaris Therapeutics Inc's drug to treat a common kind of skin growth called seborrheic keratoses received approval from the U.S. Food and Drug...
    Canadian police probe mysterious deaths of billionaire pharma couple

    Canadian police probe mysterious deaths of billionaire pharma couple

    Ruby Khatun Khatun18 Dec 2017 9:45 AM IST
    TORONTO: Canadian police are investigating the mysterious deaths of pharmaceuticals billionaire Barry Sherman, founder of Apotex Inc, and his wife...
    Novartis generics arm says may sell or end some products

    Novartis generics arm says may sell or end some products

    Ruby Khatun Khatun18 Dec 2017 9:30 AM IST
    ZURICH: Swiss drugmaker Novartis's Sandoz generics business is in the process of selling or closing some products in the United States, it said on...
    15,000 diabetics sign petition to slash glucostrips price

    15,000 diabetics sign petition to slash glucostrips price

    Ruby Khatun Khatun17 Dec 2017 11:00 AM IST
    Mumbai: In a move to curb the price of glucostrips more than 15,000 people have signed an online petition seeking a reduction in the cost of...
    Siemens buys Fast Track Diagnostics to boost molecular offering

    Siemens buys Fast Track Diagnostics to boost molecular offering

    Ruby Khatun Khatun17 Dec 2017 10:45 AM IST
    FRANKFURT: Siemens said it has agreed to buy Luxembourg-based Fast Track Diagnostics to boost its molecular-testing offering, one of the areas it is...
    PrevNext

    Popular Stories

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok